[1] 陈寿坡，蒋明，刘彤华，等．干燥综合征对胃肠道和胰腺外分泌功能的影响[J]．中华内科杂志，1987，26：698-700.

[2] 张顺华，卞爱玲，赵岩，等．角膜结膜染色评分新方法在原发性干燥综合征的应用[J]．中华临床免疫和变态反应杂志，2013，7（2）：134-138.

[3] BiasiD, Caramaschi P, Ambrosetti A, et al. Mucosa-associated lymphoid tissue lymphoma of the salivary glands occurring in patients affectedby Sjögren's syndrome: report of 6 cases[J]. Acta Haematol, 2001, 105(2): 83-88.

[4] Daniels TE, Silverman S Jr, Michalski JP, et al. The oral component of Sjögren's syndrome[J].Oral Surg Oral Med Oral Pathol, 1975, 39(6): 875-885.

[5] Ferraccioli G, Damato R, De Vita S, et al. Haematopoietic stem cell transplantation(HSCT)in a patient with Sjögren's syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease[J]. Ann Rheum Dis, 2001, 60(2): 174-176.

[6] Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases[J]. Arthritis Rheum, 1984, 27(2): 147-156.

[7] Fox RI. Fifth international symposium on Sjögren's syndrome[J]. Arthritis Rheum, 1996, 39(2): 195-196.

[8] Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial[J]. Arch Intern Med, 2002, 162(11): 1293-1300.

[9] Huo AP1, Lin KC, Chou CT. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjögren's syndrome[J]. Int J Rheum Dis, 2010, 13(1): 39-47.

[10] Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis[J]. Rheum Dis Clin North Am, 2008, 34(4): 921-933.

[11] Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982, 25(11): 1271-1277.

[12] Fox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome. Proposed criteria for classification[J].Arthritis Rheum, 1986, 29(5): 577-585.

[13] Manthorpe R, Oxholm P, Prause JU, et al. The Copenhagen criteria for Sjögren's syndrome[J].Scand J Rheumatol Suppl, 1986, 61: 19-21.

[14] Skopouli FN, Drosos AA, Papaioannou T, et al. Preliminary diagnostic criteria for Sjögren's syndrome[J]. Scand J Rheumatol Suppl, 1986, 61: 22-25.

[15] Arnett FC1, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988, 31(3): 315-324.

[16] Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community[J]. Arthritis Rheum, 1993, 36(3): 340-347.

[17] Fox RI, Saito I. Criteria for diagnosis of Sjögren's syndrome[J]. Rheum Dis Clin North Am, 1994, 20(2): 391-407.

[18] Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study[J].J Intern Med, 1996, 239(6): 475-482.

[19] Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61(6): 55.

[20] Fujibayashi T, Sugai S, Miyasaka N, et al. Revised Japanese criteria for Sjögren's syndrome(1999): availability and validity[J]. Mod Rheumatol, 2004, 14(6): 425-434.

[21] Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M, et al. Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria[J]. Clin Rev Allergy Immunol, 2010, 38(2-3): 178-185.

[22] Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort[J]. Arthritis Care Res(Hoboken), 2012, 64(4): 475-487.

[23] Baldini C, Talarico R, Tzioufas AG, et al. Classification criteria for Sjögren's syndrome: a critical review[J]. J Autoimmun, 2012, 39(1-2): 9-14.

[24] Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjögren syndrome patients according to serological profiles[J]. J Autoimmun, 2012, 39(1-2): 15-26.

[25] Ter Borg EJ1, Risselada AP, Kelder JC. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands[J]. Semin Arthritis Rheum, 2011, 40(6): 547-551.

[26] Fauchais AL, Martel C, Gondran G, et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease[J].Autoimmun Rev, 2010, 9(9): 595-599.

[27] 李梦涛，赵岩，郑文洁，等．抗SSA抗体在原发性干燥综合征的诊断价值[J]．中华内科杂志，2010，49（45）．

[28] Lyons R, Narain S, Nichols C, et al. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease[J]. Ann N Y Acad Sci, 2005, 1050: 217-228.

[29] 方万，何菁，姚中强，等．抗毒蕈碱受体3多肽抗体测定在干燥综合征诊断中的意义[J]．中华风湿病学杂志，2008，12（4）：226-229.

[30] Dawson L1, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?[J]. Arthritis Rheum, 2005, 52(10): 2984-2995.

[31] 蔡逸婷，刘庆中，赵超，等．联合检测抗α合胞衬蛋白、抗SSA和抗SSB抗体在干燥综合征诊断中的应用[J]．现代免疫学，2012，4（2）：91-96.